138 related articles for article (PubMed ID: 15705280)
1. Fatal Kaposi's sarcoma-associated immune reconstitution following HAART initiation.
Crane HM; Deubner H; Huang JC; Swanson PE; Harrington RD
Int J STD AIDS; 2005 Jan; 16(1):80-3. PubMed ID: 15705280
[TBL] [Abstract][Full Text] [Related]
2. Fatal Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral therapy.
Kawsar M
Int J STD AIDS; 2005 Aug; 16(8):582-3; author reply 583. PubMed ID: 16105195
[No Abstract] [Full Text] [Related]
3. Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome.
Leidner RS; Aboulafia DM
AIDS Patient Care STDS; 2005 Oct; 19(10):635-44. PubMed ID: 16232048
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral treatment initiation.
Chan DJ
Int J STD AIDS; 2006 Jan; 17(1):72. PubMed ID: 16409689
[No Abstract] [Full Text] [Related]
6. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
[TBL] [Abstract][Full Text] [Related]
7. AIDS associated Kaposi's sarcoma.
Thomas S; Sindhu CB; Sreekumar S; Sasidharan PK
J Assoc Physicians India; 2011 Jun; 59():387-9. PubMed ID: 21751599
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma in pregnancy after initiation of highly active antiretroviral therapy: a manifestation of immune reconstitution syndrome.
Adeyemo A; Wood C; Govind A
Int J STD AIDS; 2012 Dec; 23(12):905-6. PubMed ID: 23258835
[TBL] [Abstract][Full Text] [Related]
9. Regression of Kaposi's sarcoma lesions following highly active antiretroviral therapy in an HIV-infected patient.
Kumarasamy N; Venkatesh KK; Devaleenol B; Poongulali S; Ahilasamy N
Int J STD AIDS; 2008 Nov; 19(11):786-8. PubMed ID: 18931277
[TBL] [Abstract][Full Text] [Related]
10. Chronic cough conundrum: a case report of a new diagnosis of HIV and pulmonary Kaposi's sarcoma.
Bailey PP; Dryer MM; Piper JP; Ahmad S
BMC Pulm Med; 2017 Mar; 17(1):52. PubMed ID: 28320359
[TBL] [Abstract][Full Text] [Related]
11. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.
Loke WC; Spittle MF; Mitchell S; Kulasegaram R
Int J STD AIDS; 2006 Aug; 17(8):565-6. PubMed ID: 16925908
[TBL] [Abstract][Full Text] [Related]
12. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
[TBL] [Abstract][Full Text] [Related]
13. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
Martinez V; Caumes E; Gambotti L; Ittah H; Morini JP; Deleuze J; Gorin I; Katlama C; Bricaire F; Dupin N
Br J Cancer; 2006 Apr; 94(7):1000-6. PubMed ID: 16570046
[TBL] [Abstract][Full Text] [Related]
14. Management of Kaposi's sarcoma in resource-limited settings in the era of HAART.
Lynen L; Zolfo M; Huyst V; Louis F; Barnardt P; Van de Velde A; De Schacht C; Colebunders R
AIDS Rev; 2005; 7(1):13-21. PubMed ID: 15875657
[TBL] [Abstract][Full Text] [Related]
15. Steroid-exacerbated HIV-associated cutaneous Kaposi's sarcoma immune reconstitution inflammatory syndrome: 'Where a good intention turns bad'.
Chabria S; Barakat L; Ogbuagu O
Int J STD AIDS; 2016 Oct; 27(11):1026-9. PubMed ID: 26769754
[TBL] [Abstract][Full Text] [Related]
16. Recurrent lower gastrointestinal bleeding due to primary colonic Kaposi's sarcoma in a patient with AIDS.
Ling J; Coron R; Basak P; Jesmajian S
Int J STD AIDS; 2013 Nov; 24(11):908-11. PubMed ID: 23970616
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda.
Asiimwe F; Moore D; Were W; Nakityo R; Campbell J; Barasa A; Mermin J; Kaharuza F
HIV Med; 2012 Mar; 13(3):166-71. PubMed ID: 22112164
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
[TBL] [Abstract][Full Text] [Related]
19. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
Bower M; Nelson M; Young AM; Thirlwell C; Newsom-Davis T; Mandalia S; Dhillon T; Holmes P; Gazzard BG; Stebbing J
J Clin Oncol; 2005 Aug; 23(22):5224-8. PubMed ID: 16051964
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma.
Stebbing J; Gazzard B; Flore O; Thomas C; Benlahrech A; Mandalia S; Bower M; Gotch F; Patterson S
AIDS; 2003 Sep; 17(13):1998-2000. PubMed ID: 12960839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
